Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.40 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.39 |
| ▸ | RGS12 | O14924 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL277446 | 0.85 | LMNA (0.50) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL13979666 | 0.84 | LMNA (0.48) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL1607377 | 0.82 | LMNA (0.51) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL4120039 | 0.79 | ALDH1A1 (0.50) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL535804 | 0.78 | ALDH1A1 (0.49) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL464397 | 0.77 | LMNA (0.39) | LMNASMN1; SMN2POLBALDH1A1RAB9A | |
| SCHEMBL2902840 | 0.76 | LMNA (0.48) | LMNASMN1; SMN2ALDH1A1RAB9AKDM4E | |
| SCHEMBL12109353 | 0.75 | ALDH1A1 (0.46) | LMNASMN1; SMN2ALDH1A1RAB9AHPGD | |
| SCHEMBL2912510 | 0.75 | LMNA (0.49) | LMNASMN1; SMN2ALDH1A1RAB9AKDM4E | |
| SCHEMBL20061725 | 0.75 | ALDH1A1 (0.49) | LMNASMN1; SMN2POLBALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329876-B2 | Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith | NEKTAR THERAPEUTICS (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120065330-A1 | Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith | NEKTAR THERAPEUTICS (US) | 2012-03-15 | — | — | US | disclosed |
| US-8071678-B2 | Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith | NEKTAR THERAPEUTICS (US) | 2011-12-06 | — | — | US | disclosed |
| US-20110065862-A1 | Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith | NEKTAR THERAPEUTICS (US) | 2011-03-17 | — | — | US | disclosed |
| US-7834088-B2 | Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith | NEKTAR THERAPEUTICS (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100069571-A1 | Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith | NEKTAR THERAPEUTICS (US) | 2010-03-18 | — | — | US | disclosed |
| US-7511095-B2 | Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069571-A1 | Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith | PCTP, CETP, NGLY1 | LMNA 2605/4885SMN1; SMN2 4702/4885POLB 4122/4885 |
| US-20120065330-A1 | Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith | PCTP, CETP, NGLY1 | LMNA 2605/4885SMN1; SMN2 4702/4885POLB 4122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.